Tuesday, 16th of May 2017 |
Prevention of Chronic Hepatitis B after 3 Decades of Escalating Vaccination Policy, China
Now that we have 30 years’ experience with hep B vaccination from the early adopters, including China, we are beginning to quantify the long term benefits. There are still policy issues: the birth dose, which is not yet universal in much of the world, and hep B vaccination of high risk groups, especially physicians and nurses.
Full text is at https://wwwnc.cdc.gov/eid/article/23/5/16-1477_article
Are three drugs for malaria better than two?
Friday, 24th of April 2020 |
Public health Interventions and epidemic intensity during the 1918 influenza pandemic
Thursday, 16th of April 2020 |
Chloroquine and hydroxychloroquine as available weapons to fight COVID-19
Tuesday, 17th of March 2020 |
Using models to shape measles control and elimination strategies in low- and middle-income countries: A review of recent applications
Monday, 17th of February 2020 |
Immunization Agenda 2030
Tuesday, 11th of February 2020 |
40920015 |
www.measlesinitiative.org www.technet21.org www.polioeradication.org www.globalhealthlearning.org www.who.int/bulletin allianceformalariaprevention.com www.malariaworld.org http://www.panafrican-med-journal.com/ |